The China Fund, Inc Records First Quarter Results prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Dec 17, 2020
China’s central bank is striking out on its own with signals of tighter monetary policy, widening a divergence with other large economies that will shape global capital and trade flows next year.
With most of the world’s major nations still battling the pandemic and struggling to recover from deep recessions, China’s economy is on track to grow by about 2% this year and more than 8% in 2021.
That’s allowing People’s Bank of China Gov. Yi Gang to turn his attention to a record debt burden, an issue that’s come into sharp focus following a spate of corporate defaults in recent weeks.
CASI Pharmaceuticals Announces Appointment Of Chief Financial Officer
News provided by
Share this article
Share this article
ROCKVILLE, Md., and BEIJING, Dec. 16, 2020 /PRNewswire/ CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announces the appointment of Weihao Xu to the position of Chief Financial Officer. Mr. Xu will report to Dr. Wei-Wu He, Chairman and CEO of CASI.
Most recently, in January 2020, Mr. Xu founded and served as Chief Investment Officer for Permanence Capital LLC, a healthcare-dedicated investment firm. From February 2018 until March 2019, he served as Chief Financial Officer for 111, Inc. a Shanghai-based digital healthcare company, where he led the initial public offering of the company on NASDAQ, and oversaw the company s financial operations, corporate strategy and investor relations. Prior to that, Mr. Xu served as a portfoli